Review



active ras detection kit  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Cell Signaling Technology Inc active ras detection kit
    Active Ras Detection Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 148 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/active+ras+detection+kit/Active+Ras+Detection+Kit/pm41620418-294-6-10
    Average 95 stars, based on 148 article reviews
    active ras detection kit - by Bioz Stars, 2026-09
    95/100 stars

    Images

    Related Articles

    Activation Assay:

    Article Title: Personalized pharmacokinetic-pharmacodynamic guided therapy via an induced pluripotent stem cell-derived multi-organoid platform in NF1-mutant breast cancer.
    Article Snippet: .. Ras Activation Assay Ras activity in tissues and isolated primary cells was assessed using the Active Ras Detection Kit (Cell Signaling Technology, Danvers, MA, USA) according to the manufacturer’s instructions. ..

    Activity Assay:

    Article Title: Personalized pharmacokinetic-pharmacodynamic guided therapy via an induced pluripotent stem cell-derived multi-organoid platform in NF1-mutant breast cancer.
    Article Snippet: .. Ras Activation Assay Ras activity in tissues and isolated primary cells was assessed using the Active Ras Detection Kit (Cell Signaling Technology, Danvers, MA, USA) according to the manufacturer’s instructions. ..

    Article Title: Personalized pharmacokinetic–pharmacodynamic guided therapy via an induced pluripotent stem cell–derived multi-organoid platform in NF1-mutant breast cancer
    Article Snippet: .. Ras activity in tissues and isolated primary cells was assessed using the Active Ras Detection Kit (Cell Signaling Technology, Danvers, MA, USA) according to the manufacturer’s instructions. ..

    Isolation:

    Article Title: Personalized pharmacokinetic-pharmacodynamic guided therapy via an induced pluripotent stem cell-derived multi-organoid platform in NF1-mutant breast cancer.
    Article Snippet: .. Ras Activation Assay Ras activity in tissues and isolated primary cells was assessed using the Active Ras Detection Kit (Cell Signaling Technology, Danvers, MA, USA) according to the manufacturer’s instructions. ..

    Article Title: Covalent inhibitor design confers activity against both GDP- and GTP-bound forms of KRAS G12C.
    Article Snippet: .. Active RAS was isolated using the Active Ras Detection Kit (Cell Signaling Technology, CST-8821) according to the manufacturer’s instructions. .. Briefly, cell lysates were prepared and incubated with GST-Raf1-RBD conjugated glutathione resin for 1 h at 4 °C with gentle rocking.

    Article Title: Personalized pharmacokinetic–pharmacodynamic guided therapy via an induced pluripotent stem cell–derived multi-organoid platform in NF1-mutant breast cancer
    Article Snippet: .. Ras activity in tissues and isolated primary cells was assessed using the Active Ras Detection Kit (Cell Signaling Technology, Danvers, MA, USA) according to the manufacturer’s instructions. ..

    Article Title: Covalent inhibitor design confers activity against both GDP- and GTP-bound forms of KRAS G12C
    Article Snippet: Cells were stimulated with 100 ng/mL human epidermal growth factor (EGF; ThermoFisher, PHG0315) for 30 min. After treatment, cells were collected and washed with ice-cold PBS. .. Active RAS was isolated using the Active Ras Detection Kit (Cell Signaling Technology, CST-8821) according to the manufacturer’s instructions. .. Briefly, cell lysates were prepared and incubated with GST-Raf1-RBD conjugated glutathione resin for 1 h at 4 °C with gentle rocking.

    Incubation:

    Article Title: Compounds that interact with RAS superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
    Article Snippet: Equal amounts of lysate were then added to 0.5 mL lysis buffer containing RAF-RBD (1 mL total volume). .. Lysates were vortexed, incubated for 10 min on ice and subsequently pre-cleared at 14,000 rpm for 5 min at 4° C. 90% of the pre-cleared lysates were subsequently added to pre-washed glutathione agarose beads from Active Ras Detection kit (Cell signaling Technology, #8821) for 1 hour at 4° C. under constant rocking. ..

    Lysis:

    Article Title: Identification of Small-Molecule Inhibitors that Block the GTP-Binding Pocket of K-Ras and Other Members of the Ras Superfamily of Small GTPases
    Article Snippet: .. Next, cells were stimulated with 1.5 ng/mL EGF for 15 minutes, rinsed with ice-cold PBS, and lysed with 200 μL of lysis/binding/wash buffer from the Active Ras Detection kit (Cell Signaling Technology, #8821) supplemented with phenylmethylsulfonyl fluoride (Sigma). ..



    Similar Products

    95
    Cell Signaling Technology Inc active ras detection kit
    Active Ras Detection Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/active+ras+detection+kit/Active+Ras+Detection+Kit/pm41620418-294-6-10
    Average 95 stars, based on 1 article reviews
    active ras detection kit - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc ras activation assay kit
    A . Western blots showing levels of pERK, total ERK, pAKT, total AKT, non-phospho-β-catenin, total β-catenin, LC3A/B, cleaved PARP, and cleaved caspase 3 in 2838c3- f -luc tumors after vehicle or ADT-030 treatment. B-G . Bar graphs representing the quantifications of western blots from panel A: pERK ( B ), p-AKT ( C ), non-phospho-β-catenin ( D ), LC3A/B ( E ), cleaved PARP ( F ), and cleaved caspase 3 ( G ) in tumor tissues after ADT-030 vs. vehicle treatments. Welch t -test was used for statistical analysis. H . The inhibitory effect of ADT-030 on <t>activated</t> <t>(GTP-bound)</t> <t>RAS</t> in tumors after vehicle or ADT-030 treatments was assessed by RAS-RBD pull-down assay. I . Representative Ki-67 IHC results in tumors after vehicle or ADT-030 treatment. J-L . Representative IF images of LC3A/B (J) , vimentin (K) , and E-Cadherin (L) in tumors after vehicle or ADT-030 treatment. M . Bar graph representing the quantification of IHC staining for KI-67. N-P . Dot-plot graphs representing the IF quantifications of LC3A/B (N) , vimentin (O) , and E-Cadherin (P) in tumors after vehicle or ADT-030 treatment. Welch t-test was used for statistical analysis. ns, non-significant, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗∗p < 0.0001.
    Ras Activation Assay Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/active+ras+detection+kit/Active+Ras+Detection+Kit/bio_rxiv__64898__2026__02__11__705411-97-9-13
    Average 95 stars, based on 1 article reviews
    ras activation assay kit - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc active ras detection kit 159
    A . Western blots showing levels of pERK, total ERK, pAKT, total AKT, non-phospho-β-catenin, total β-catenin, LC3A/B, cleaved PARP, and cleaved caspase 3 in 2838c3- f -luc tumors after vehicle or ADT-030 treatment. B-G . Bar graphs representing the quantifications of western blots from panel A: pERK ( B ), p-AKT ( C ), non-phospho-β-catenin ( D ), LC3A/B ( E ), cleaved PARP ( F ), and cleaved caspase 3 ( G ) in tumor tissues after ADT-030 vs. vehicle treatments. Welch t -test was used for statistical analysis. H . The inhibitory effect of ADT-030 on <t>activated</t> <t>(GTP-bound)</t> <t>RAS</t> in tumors after vehicle or ADT-030 treatments was assessed by RAS-RBD pull-down assay. I . Representative Ki-67 IHC results in tumors after vehicle or ADT-030 treatment. J-L . Representative IF images of LC3A/B (J) , vimentin (K) , and E-Cadherin (L) in tumors after vehicle or ADT-030 treatment. M . Bar graph representing the quantification of IHC staining for KI-67. N-P . Dot-plot graphs representing the IF quantifications of LC3A/B (N) , vimentin (O) , and E-Cadherin (P) in tumors after vehicle or ADT-030 treatment. Welch t-test was used for statistical analysis. ns, non-significant, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗∗p < 0.0001.
    Active Ras Detection Kit 159, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/active+ras+detection+kit/Active+Ras+Detection+Kit/10__1158_slash_0008___5472__can___25___2630-80-31-36
    Average 95 stars, based on 1 article reviews
    active ras detection kit 159 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    95
    Cell Signaling Technology Inc ras detection kit
    A . Western blots showing levels of pERK, total ERK, pAKT, total AKT, non-phospho-β-catenin, total β-catenin, LC3A/B, cleaved PARP, and cleaved caspase 3 in 2838c3- f -luc tumors after vehicle or ADT-030 treatment. B-G . Bar graphs representing the quantifications of western blots from panel A: pERK ( B ), p-AKT ( C ), non-phospho-β-catenin ( D ), LC3A/B ( E ), cleaved PARP ( F ), and cleaved caspase 3 ( G ) in tumor tissues after ADT-030 vs. vehicle treatments. Welch t -test was used for statistical analysis. H . The inhibitory effect of ADT-030 on <t>activated</t> <t>(GTP-bound)</t> <t>RAS</t> in tumors after vehicle or ADT-030 treatments was assessed by RAS-RBD pull-down assay. I . Representative Ki-67 IHC results in tumors after vehicle or ADT-030 treatment. J-L . Representative IF images of LC3A/B (J) , vimentin (K) , and E-Cadherin (L) in tumors after vehicle or ADT-030 treatment. M . Bar graph representing the quantification of IHC staining for KI-67. N-P . Dot-plot graphs representing the IF quantifications of LC3A/B (N) , vimentin (O) , and E-Cadherin (P) in tumors after vehicle or ADT-030 treatment. Welch t-test was used for statistical analysis. ns, non-significant, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗∗p < 0.0001.
    Ras Detection Kit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/active+ras+detection+kit/Active+Ras+Detection+Kit/pm41208497-107-4-8
    Average 95 stars, based on 1 article reviews
    ras detection kit - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    Image Search Results


    A . Western blots showing levels of pERK, total ERK, pAKT, total AKT, non-phospho-β-catenin, total β-catenin, LC3A/B, cleaved PARP, and cleaved caspase 3 in 2838c3- f -luc tumors after vehicle or ADT-030 treatment. B-G . Bar graphs representing the quantifications of western blots from panel A: pERK ( B ), p-AKT ( C ), non-phospho-β-catenin ( D ), LC3A/B ( E ), cleaved PARP ( F ), and cleaved caspase 3 ( G ) in tumor tissues after ADT-030 vs. vehicle treatments. Welch t -test was used for statistical analysis. H . The inhibitory effect of ADT-030 on activated (GTP-bound) RAS in tumors after vehicle or ADT-030 treatments was assessed by RAS-RBD pull-down assay. I . Representative Ki-67 IHC results in tumors after vehicle or ADT-030 treatment. J-L . Representative IF images of LC3A/B (J) , vimentin (K) , and E-Cadherin (L) in tumors after vehicle or ADT-030 treatment. M . Bar graph representing the quantification of IHC staining for KI-67. N-P . Dot-plot graphs representing the IF quantifications of LC3A/B (N) , vimentin (O) , and E-Cadherin (P) in tumors after vehicle or ADT-030 treatment. Welch t-test was used for statistical analysis. ns, non-significant, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗∗p < 0.0001.

    Journal: bioRxiv

    Article Title: ADT-030, a novel PDE10 inhibitor, demonstrates potent antitumor activity in pancreatic ductal adenocarcinoma

    doi: 10.64898/2026.02.11.705411

    Figure Lengend Snippet: A . Western blots showing levels of pERK, total ERK, pAKT, total AKT, non-phospho-β-catenin, total β-catenin, LC3A/B, cleaved PARP, and cleaved caspase 3 in 2838c3- f -luc tumors after vehicle or ADT-030 treatment. B-G . Bar graphs representing the quantifications of western blots from panel A: pERK ( B ), p-AKT ( C ), non-phospho-β-catenin ( D ), LC3A/B ( E ), cleaved PARP ( F ), and cleaved caspase 3 ( G ) in tumor tissues after ADT-030 vs. vehicle treatments. Welch t -test was used for statistical analysis. H . The inhibitory effect of ADT-030 on activated (GTP-bound) RAS in tumors after vehicle or ADT-030 treatments was assessed by RAS-RBD pull-down assay. I . Representative Ki-67 IHC results in tumors after vehicle or ADT-030 treatment. J-L . Representative IF images of LC3A/B (J) , vimentin (K) , and E-Cadherin (L) in tumors after vehicle or ADT-030 treatment. M . Bar graph representing the quantification of IHC staining for KI-67. N-P . Dot-plot graphs representing the IF quantifications of LC3A/B (N) , vimentin (O) , and E-Cadherin (P) in tumors after vehicle or ADT-030 treatment. Welch t-test was used for statistical analysis. ns, non-significant, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗∗p < 0.0001.

    Article Snippet: RAS activation (RAS-GTP) levels were measured using the active RAS activation assay kit (Cell Signaling Technology, Cat# 8821).

    Techniques: Western Blot, Pull Down Assay, Immunohistochemistry